Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Biocon Limited

BIOCON
Current price
391.2 INR +8.69 INR (+2.27%)
Last closed 378.95 INR
ISIN INE376G01013
Sector Healthcare
Industry Biotechnology
Exchange National Stock Exchange of India
Capitalization 453 276 610 537 INR
Yield for 12 month +43.19 %
1Y
3Y
5Y
10Y
15Y
BIOCON
21.11.2021 - 28.11.2021

Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India. Address: 20th KM Hosur Road, Bengaluru, India, 560100

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

25 727.68 INR

P/E ratio

28.4925

Dividend Yield

0.13 %

Current Year

+147 419 973 786 INR

Last Year

+111 638 232 700 INR

Current Quarter

+34 297 120 931 INR

Last Quarter

+39 134 624 539 INR

Current Year

+57 033 987 143 INR

Last Year

+75 041 249 441 INR

Current Quarter

+11 204 585 353 INR

Last Quarter

+15 112 952 546 INR

Key Figures BIOCON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 32 688 615 647 INR
Operating Margin TTM 6.26 %
PE Ratio 28.4925
Return On Assets TTM 2.06 %
PEG Ratio
Return On Equity TTM 5.43 %
Wall Street Target Price 25 727.68 INR
Revenue TTM 147 522 875 301 INR
Book Value 165.15 INR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 0.3 %
Dividend Yield 0.13 %
Gross Profit TTM 54 605 244 658 INR
Earnings per share 13.29 INR
Diluted Eps TTM 13.29 INR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 548.2 %
Profit Margin 10.71 %

Dividend Analytics BIOCON

Dividend growth over 5 years

200 %

Continuous growth

1 year

Payout Ratio 5 years average

18 %

Dividend History BIOCON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.5
Ex Dividend Date 05.07.2024
Forward Annual Dividend Yield 0.13 %
Last Split Factor 2:1
Payout Ratio 3.9 %
Last Split Date 12.06.2019
Dividend Date

Stock Valuation BIOCON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 28.4925
Forward PE
Enterprise Value Revenue 4.1074
Price Sales TTM 3.0726
Enterprise Value EBITDA 11.4647
Price Book MRQ 2.2791

Financials BIOCON

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BIOCON

For 52 weeks

217 INR 394.53 INR
50 Day MA 354.66 INR
Shares Short Prior Month
200 Day MA 304.01 INR
Short Ratio
Shares Short
Short Percent